Keybanc Maintains Overweight on BKV, Raises Price Target to $35

BKV Corporation

BKV Corporation

BKV

0.00

Keybanc analyst Tim Rezvan maintains BKV (NYSE: BKV) with a Overweight and raises the price target from $34 to $35.